Chief Medical Officer

Dr.Bruce Charlesworth

Bruce is a non-executive Director, serving as Chief Medical Officer here at Moodbeam. He qualified in medicine in 1996 and subsequently trained in anaesthetics and intensive care.

After spending 5 years in clinical practice he moved into the healthcare product industry with the ambition of using his medical knowledge and commercial acumen to innovate and improve lives on a global scale. Working for AstraZeneca and Pfizer initially, Bruce helped develop and launch an array of pharmaceuticals across a range of indications such as pain, depression and headache. Subsequently Bruce led a start up diagnostics business before taking the world-renowned health outcomes agency Adelphi Values through 5 years of growth as the Global President.

For the past 5 years Bruce has been a senior executive in at RB, a leading health and consumer goods company famous for global household brands such as Dettol, Durex, Nurofen, Gaviscon, Strepsils and Scholl. Bruce is Chief Medical Officer for RB’s Relief, Wellness and Hygiene portfolio and also leads the Hull R&D site. With his medical credentials and hands on experience of product development, clinical trials and outcomes research Bruce is a driving force behind ensuring Moodbeam is proven, credible and purpose-led.